Ryan Lynch

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Waltham, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Barbara Bispham Hale, as attorney-in-fact for Ryan Lynch
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Ryan Lynch

Form 4 holding Treasurer, Senior Vice President of Finance and Chief Accounting Officer.

CRESCENT BIOPHARMA, INC.

Security class
Stock Option (Right to Buy)
Shares / value
33,512
Estimated value
Report date
15 Dec 2025
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Ryan Lynch

3 GLYC

GLYCOMIMETICS INC

Report period
13 Jun 2025
Transactions
0
Transaction value
$0
Accepted by SEC
23 Jun 2025, 18:29
Role
Treasurer, Senior Vice President of Finance and Chief Accounting Officer. Exhibit 24 - Power of Attorney
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .